Home > Research > Researchers > Professor David Allsop > Publications

Professor David Allsop

Professor

  1. 2020
  2. Published

    Apathy as a behavioural marker of cognitive impairment in Parkinson's disease: a longitudinal analysis

    Martin, G. P., McDonald, K. R., Allsop, D., Diggle, P. J. & Leroi, I., 1/01/2020, In : Journal of Neurology. 267, 1, p. 214-227 14 p.

    Research output: Contribution to journalJournal article

  3. 2019
  4. Published

    Combined use of CSF NfL and CSF TDP-43 improves diagnostic performance in ALS: A comprehensive analysis on diagnostic and prognostic significance of plasma and CSF NfL, TDP-43, and tau

    Kasai, T., Kojima, Y., Ohmichi, T., Tatebe, H., Tsuji, Y., Noto, Y., Kitani-Morii, F., Shinomoto, M., Allsop, D., Mizuno, T. & Tokuda, T., 1/12/2019, In : Annals of Clinical and Translational Neurology. 6, 12, p. 2489-2502 14 p.

    Research output: Contribution to journalJournal article

  5. Published

    Plasma neurofilament light chain: A potential prognostic biomarker of dementia in adult Down syndrome patients

    Shinomoto, M., Kasai, T., Tatebe, H., Kondo, M., Ohmichi, T., Morimoto, M., Chiyonobu, T., Terada, N., Allsop, D., Yokota, I., Mizuno, T. & Tokuda, T., 5/04/2019, In : PLoS ONE. 14, 4, 13 p., e0211575.

    Research output: Contribution to journalJournal article

  6. 2018
  7. Published

    Blood-based near-infrared spectroscopy for the rapid low-cost detection of Alzheimer’s disease

    Paraskevaidi, M., Morais, C., Freitas, D., Lima, K., Mann, D., Allsop, D., Martin-Hirsch, P. & Martin, F. L., 21/12/2018, In : Analyst. 143, 24, p. 5959-5964 6 p.

    Research output: Contribution to journalJournal article

  8. Published

    Liposome delivery systems for the treatment of Alzheimer’s disease

    Ross, C., Taylor, M. N., Fullwood, N. J. & Allsop, D., 12/12/2018, In : International Journal of Nanomedicine. 2018, 13, p. 8507-8522 16 p.

    Research output: Contribution to journalJournal article

  9. Published

    Raman spectroscopy to diagnose Alzheimer's disease and dementia with Lewy bodies in blood

    Paraskevaidi, M., Morais, C., Halliwell, D., Mann, D., Allsop, D., Martin-Hirsch, P. & Martin, F. L., 2018, In : ACS Chemical Neuroscience. 9, 11, p. 2786–2794 9 p.

    Research output: Contribution to journalJournal article

  10. Published

    Untangled - peptide-based inhibitors of tau aggregation as a potential treatment for Alzheimer's disease

    Allsop, D., Aggidis, A., Fullwood, N. J., Taylor, M. N., Foulds, P., Vincent, S. & Dale, M., 2018, In : Journal of Prevention of Alzheimer's Disease. 5, Suppl 1, p. S15-S16 2 p.

    Research output: Contribution to journalMeeting abstract

  11. 2017
  12. Published

    Development of proteolytically stable N-methylated peptide inhibitors of aggregation of the amylin peptide implicated in type 2 diabetes

    Obasse, I. C., Taylor, M. N., Fullwood, N. J. & Allsop, D., 6/12/2017, In : Interface Focus. 7, 6, 11 p., 20160127.

    Research output: Contribution to journalJournal article

  13. Published

    Increased levels of plasma total tau in adult Down syndrome

    Kasai, T., Tatebe, H., Kondo, M., Ishii, R., Ohmichi, T., Yeung, W. T. E., Morimoto, M., Chiyonobu, T., Terada, N., Allsop, D., Nakagawa, M., Mizuno, T. & Tokuda, T., 30/11/2017, In : PLoS ONE. 12, 11, 12 p., e0188802.

    Research output: Contribution to journalJournal article

  14. Published

    A novel approach to the therapy of Alzheimer's disease based on peptide nanoliposome inhibitors of Aβ and tau aggregation

    Allsop, D., Taylor, M. N., Fullwood, N. J., Michael, M., Aggidis, A., Vincent, S. & Dale, M., 1/11/2017, In : Journal of Prevention of Alzheimer's Disease. 4, 4, p. 385-386 2 p.

    Research output: Contribution to journalMeeting abstract

  15. Published

    α-Synuclein interacts with lipoproteins in plasma

    Nouri Emamzadeh, F. & Allsop, D., 10/2017, In : Journal of Molecular Neuroscience . 63, 2, p. 165-172 8 p.

    Research output: Contribution to journalJournal article

  16. Published

    Differential diagnosis of Alzheimer’s disease using spectrochemical analysis of blood

    Paraskevaidi, M., Morais, C., Lima, K., Snowden, J., Saxon, J., Richardson, A., Jones, M., Mann, D., Allsop, D., Martin-Hirsch, P. & Martin, F., 19/09/2017, In : Proceedings of the National Academy of Sciences of the United States of America. 114, 38, p. E7929–E7938 10 p.

    Research output: Contribution to journalJournal article

  17. Published

    Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer’s disease and Down syndrome

    Tatebe, H., Kasai, T., Ohmichi, T., Kishi, Y., Kakeya, T., Waragai, M., Kondo, M., Allsop, D. & Tokuda, T., 4/09/2017, In : Molecular Neurodegeneration. 12, 63, 11 p., 63.

    Research output: Contribution to journalJournal article

  18. Published

    Aβ levels in the jugular vein and high molecular weight Aβ oligomer levels in CSF can be used as biomarkers to indicate the anti-amyloid effect of IVIg for Alzheimer's disease

    Kasai, T., Kondo, M., Ishii, R., Tanaka, A., Ataka, S., Shimada, H., Tomiyama, T., Mori, H., Taylor, M. N., Allsop, D., Nakagawa, M., Mizuno, T. & Tokuda, T., 10/04/2017, In : PLoS ONE. 12, 4

    Research output: Contribution to journalJournal article

  19. Published

    Self-Assembly and Anti-Amyloid Cytotoxicity Activity of Amyloid beta Peptide Derivatives

    Castelletto, V., Ryumin, P., Cramer, R., Hamley, I., Taylor, M. N., Allsop, D., Reza, M., Ruokolainen, J., Arnold, T., Hermida-Merino, D., Garcia, C. I., Leal, M. C. & Castaño, E., 8/03/2017, In : Scientific Reports. 7, 12 p., 43637.

    Research output: Contribution to journalJournal article

  20. Published

    ß-Hairpin mimics containing a piperidine-pyrrolidine scaffold modulate the ß-amyloid aggregation process preserving the monomer species

    Pellegrino, S., Tonali, N., Erba, E., Kaffy, J., Taverna, M., Contini, A., Taylor, M. N., Allsop, D., Gelmi, M. L. & Ongeri, S., 1/02/2017, In : Chemical Science. 8, 2, p. 1295-1302 8 p.

    Research output: Contribution to journalJournal article

  21. Published

    Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer’s Aβ peptide

    Gregori, M., Taylor, M. N., Salvati, E., Re, F., Mancini, S., Balducci, C., Forloni, G., Zambelli, V., Sesana, S., Michael, M., Michail, C., Kolosov, O. V., Tinker-Mill, C. L., Sherer, M., Harris, S., Fullwood, N. J., Masserini, M. & Allsop, D., 02/2017, In : Nanomedicine: Nanotechnology, Biology, and Medicine. 13, 2, p. 723-732 10 p.

    Research output: Contribution to journalJournal article

  22. 2016
  23. Published

    Development and automation of a novel [18F]Fprosthetic group, 2-[18F]-fluoro-3-pyridinecarboxaldehyde, and its application to an amino(oxy)-functionalised Aβ peptide

    Morris, O., Gregory, J., Kadirvel, M., Henderson, F., Blykers, A., McMahon, A., Taylor, M. N., Allsop, D., Allan, S., Grigg, J., Boutin, H. & Prenant, C., 10/2016, In : Applied Radiation and Isotopes. 116, p. 120-127 8 p.

    Research output: Contribution to journalJournal article

  24. Published

    Magnetite pollution nanoparticles in the human brain

    Maher, B. A., Ahmed, I., Karloukovski, V. V., MacLaren, D., Foulds, P., Allsop, D., Mann, D., Torres-Jardon, R. & Calderon-Garciduenas, L., 27/09/2016, In : Proceedings of the National Academy of Sciences of the United States of America. 113, 39, p. 10797-10801 5 p.

    Research output: Contribution to journalJournal article

  25. Published

    Effects of different isoforms of apoE on aggregation of the α- synuclein protein implicated in Parkinson's disease

    Nouri Emamzadeh, F., Aojula, H., McHugh, P. & Allsop, D., 8/04/2016, In : Neuroscience Letters. 618, p. 146-151 6 p.

    Research output: Contribution to journalJournal article

  26. Published

    Designed glycopeptidomimetics disrupt protein−protein interactions mediating amyloid β‑peptide aggregation and restore neuroblastoma cell viability

    Kaffy, J., Brinet, D., Soulier, J-L., Tonali, N., Fera, K. F., Iacone, Y., Hoffmann, A. R. F., Khemtemourian, L., Crousse, B., Taylor, M. N., Allsop, D., Taverna, M., Lequin, O. & Ongeri, S., 10/03/2016, In : Journal of Medicinal Chemistry. 59, 5, p. 2025-2040 16 p.

    Research output: Contribution to journalJournal article

  27. 2015
  28. Published

    A preliminary electron microscopic investigation into the interaction between Aβ1-42 peptide and a novel nanoliposome- coupled retro-inverso peptide inhibitor, developed as a potential treatment for Alzheimer's disease

    Sherer, M., Fullwood, N. J., Taylor, M. & Allsop, D., 1/10/2015, In : Journal of Physics: Conference Series. 644, 1, 4 p., 012040.

    Research output: Contribution to journalJournal article

  29. 2014
  30. Published

    Nanomechanical and nanothermal mapping of initial stages of amyloid fibres formation

    Kolosov, O., Tovee, P., Tinker-Mill, C. & Allsop, D., 15/09/2014, p. 29. 1 p.

    Research output: Contribution to conference - Without ISBN/ISSN Abstract

  31. Published

    Amyloid β-peptide and Alzheimer's disease

    Allsop, D. & Mayes, J., 18/08/2014, In : Essays in Biochemistry. 56, p. 99-110 12 p., 7.

    Research output: Contribution to journalLiterature review

  32. Published

    Amyloid-β fibrils in Alzheimer's Disease are not inert when bound to copper ions but can degrade hydrogen peroxide and generate reactive oxygen species

    Mayes, J., Tinker-Mill, C., Kolosov, O., Zhang, H., Tabner, B. & Allsop, D., 25/04/2014, In : Journal of Biological Chemistry. 289, p. 12052-12062 11 p.

    Research output: Contribution to journalJournal article

Previous 1 2 3 4 5 6 Next

Back to top